Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PMA SEEKING FASTER REIMBURSEMENT SETTING FROM JAPANESE

Executive Summary

PMA SEEKING FASTER REIMBURSEMENT SETTING FROM JAPANESE at a Sept. 30 meeting with Japan's Chuikyo, the Ministry of Health and Welfare's advisory council for setting reimbursement levels, Abbott Labs' Regulatory/Scientific Affairs official Robert Olson told a Sept. 25 session of the Regulatory Affairs Professionals Society (RAPS) annual meeting. Noting that "reimbursement is really the whole key to getting sales in Japan," Olson said representatives of the Pharmaceutical Manufacturers Association and the U.S. Chamber of Commerce will meet with the Chuikyo in Tokyo. "We are continually trying to push for faster reimbursement" after a product has been approved for Japanese marketing, he explained. Pharmaceutical pricing is also expected to be discussed at length. The meeting reportedly was organized after Japan's Chuikyo informed the U.S. Embassy in Tokyo that it needed advice on medical product reimbursements.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS010799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel